BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20589139)

  • 21. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of hepatitis C infection in HIV patients using a rapid one-step test strip kit.
    Akinbami AA; Oshinaike OO; Adeyemo TA; Adediran A; Oshikomaiya BI; Ismail KA
    Nig Q J Hosp Med; 2010; 20(3):144-6. PubMed ID: 21033324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
    Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
    Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients].
    DU XF; Zhang YH; Ma LN; Yan HP; Chen XY; Wu H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):345-8. PubMed ID: 18510845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.
    Roe B; Coughlan S; Dean J; Lambert JS; Keating S; Norris S; Bergin C; Hall WW
    Viral Immunol; 2009 Feb; 22(1):39-48. PubMed ID: 19210227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia.
    Mboto CI; Fielder M; Davies-Russell A; Jewell AP
    West Afr J Med; 2009 Jan; 28(1):16-9. PubMed ID: 19662739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
    Piroth L; Duong M; Quantin C; Abrahamowicz M; Michardiere R; Aho LS; Grappin M; Buisson M; Waldner A; Portier H; Chavanet P
    AIDS; 1998 Mar; 12(4):381-8. PubMed ID: 9520167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.
    Chung RT; Evans SR; Yang Y; Theodore D; Valdez H; Clark R; Shikuma C; Nevin T; Sherman KE;
    AIDS; 2002 Sep; 16(14):1915-23. PubMed ID: 12351951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy.
    Lee S; Saraswati H; Yunihastuti E; Gani R; Price P
    Clin Immunol; 2014 Dec; 155(2):149-59. PubMed ID: 25283333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.
    Thomson EC; Nastouli E; Main J; Karayiannis P; Eliahoo J; Muir D; McClure MO
    AIDS; 2009 Jan; 23(1):89-93. PubMed ID: 19050390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Rauch A; Gaudieri S; Evison J; Nolan D; Cavassini M; Weber R; James I; Furrer H;
    Antivir Ther; 2008; 13(3):455-60. PubMed ID: 18572759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
    Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
    Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
    Bailey JR; Dowd KA; Snider AE; Osburn WO; Mehta SH; Kirk GD; Thomas DL; Ray SC
    J Infect Dis; 2015 Sep; 212(6):914-23. PubMed ID: 25754978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
    Visseaux B; Larrouy L; Calin R; Katlama C; Poynard T; Ratziu V; Thibault V
    J Clin Virol; 2013 Oct; 58(2):385-90. PubMed ID: 23953940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests.
    George SL; Gebhardt J; Klinzman D; Foster MB; Patrick KD; Schmidt WN; Alden B; Pfaller MA; Stapleton JT
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):154-62. PubMed ID: 12394793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.